Changes in serum vascular endothelial growth factor following initiation of estrogen replacement after hysterectomy and oophorectomy
article
OA: bronze
CC0
Abstract
BACKGROUND: Vascular endothelial growth factor has been shown to play an important role in preservation and restoration of endothelial integrity. Similar effects on endothelial function have been described with estrogen replacement. This poses the question whether some of the mechanisms ascribed to estrogen are in fact vascular endothelial growth factor mediated. The objective of this study was to examine the effect of continuous transdermal estrogen replacement on serum levels of secreted vascular endothelial growth factor in women following hysterectomy and oophorectomy. METHODS: In a nonrandomized, prospective study, 40 hysterectomized and oophorectomized women were treated with transdermal estrogen. Their serum vascular endothelial growth factor levels were measured before and six months following estrogen treatment, using a commercially available ELISA kit. RESULTS: The mean serum vascular endothelial growth factor level fell from 328 ng/ml (s.d. 164) before treatment to 285 ng/ml (s.d. 124) following six months of estrogen replacement. This decrease was statistically significant (p<0.03). CONCLUSION: Transdermal estrogen replacement in hysterectomized and oophorectomized women appears to be associated with a significant reduction in secreted serum vascular endothelial growth factor. However, the effect of hysterectomy and oophorectomy per se needs to be explained in appropriately designed trials.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. 1996
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis 1996
References (17)
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. via openalex
- W32167704 via openalex
- doi:10.1210/endo.133.2.8344219 via openalex
- W2138843392 via openalex
- doi:10.1161/01.cir.91.11.2793 via openalex
- doi:10.1073/pnas.91.11.5212 via openalex
- doi:10.1016/s0015-0282(99)00476-8 via openalex
- doi:10.1016/0006-291x(91)91276-i via openalex
- doi:10.1038/nm1095-1024 via openalex
- doi:10.1093/cvr/28.8.1176 via openalex
- doi:10.1089/hum.1997.8.15-1737 via openalex
- doi:10.1038/nm0897-879 via openalex
- doi:10.1161/01.cir.91.11.2802 via openalex
- doi:10.1161/01.cir.98.25.2800 via openalex
- doi:10.1161/01.cir.95.4.1030 via openalex
- doi:10.1016/s0021-9150(99)00262-2 via openalex
SciLite annotations
chemicals 8
estrogen
estrogen
estrogen
estrogen
estrogen
estrogen
estrogen
estrogen
Source provenance
- openalex
- last seen: 2026-05-10T12:02:09.231096+00:00
- scilite
- last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0
· commercial use OK